Lewis H. Titterton Jr. - 10 Oct 2023 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Lewis H. Titterton, Jr.
Issuer symbol
ANIX
Transactions as of
10 Oct 2023
Net transactions value
+$41,200
Form type
4
Filing time
11 Oct 2023, 10:35:57 UTC
Previous filing
31 Jul 2023
Next filing
22 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIX Common Stock Options Exercise $41,200 +16,000 +2% $2.58 823,028 10 Oct 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option Options Exercise $0 -16,000 -100% $0.000000* 0 10 Oct 2023 Common Stock 16,000 $2.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, pursuant to a stock option grant dated January 2, 2014.